Talis Biomedical (TLIS) Short Interest Ratio & Short Volume → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free TLIS Stock Alerts $8.95 +0.23 (+2.64%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Talis Biomedical Short Interest DataCurrent Short Volume13,400 sharesPrevious Short Volume12,300 sharesChange Vs. Previous Month+8.94%Dollar Volume Sold Short$115,508.00Short Interest Ratio / Days to Cover1.5Last Record DateApril 30, 2024Outstanding Shares1,820,000 sharesFloat Size1,670,000 sharesShort Percent of Float0.80%Today's Trading Volume8,399 sharesAverage Trading Volume8,569 sharesToday's Volume Vs. Average98% Short Selling Talis Biomedical ? Sign up to receive the latest short interest report for Talis Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTLIS Short Interest Over TimeTLIS Days to Cover Over TimeTLIS Percentage of Float Shorted Over Time Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Talis Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,400 shares $115,508.00 +8.9%0.8%1.5 $8.62 4/15/202412,300 shares $104,427.00 -7.5%0.7%1.4 $8.49 3/31/202413,300 shares $116,375.00 -4.3%0.8%1.5 $8.75 3/15/202413,900 shares $126,490.00 +6.9%0.8%1.5 $9.10 2/29/202413,000 shares $104,520.00 -8.5%0.8%1.3 $8.04 2/15/202414,200 shares $121,268.00 -22.4%0.9%1.3 $8.54 Get the Latest News and Ratings for TLIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter. 1/31/202418,300 shares $142,008.00 +7.0%1.1%1.1 $7.76 1/15/202417,100 shares $139,365.00 +18.8%1.0%1 $8.15 12/31/202314,400 shares $107,280.00 -37.7%0.9%0.9 $7.45 12/15/202323,100 shares $185,955.00 +1.8%1.4%1.4 $8.05 11/30/202322,700 shares $173,655.00 +33.5%1.4%1.5 $7.65 11/15/202317,000 shares $125,120.00 -0.6%1.0%1.2 $7.36 10/31/202317,100 shares $81,738.00 +19.6%1.0%2.5 $4.78 10/15/202314,300 shares $75,791.43 +24.4%0.9%2.2 $5.30 9/30/202311,500 shares $66,355.00 -25.8%0.7%1.1 $5.77 9/15/202315,500 shares $95,945.00 +10.7%0.9%1.2 $6.19 8/31/202314,000 shares $86,800.00 -21.8%0.8%1.1 $6.20 8/15/202317,900 shares $127,448.00 -20.8%1.1%1.2 $7.12 7/31/202322,600 shares $169,048.00 -5.8%1.4%1.5 $7.48 7/15/202324,000 shares $189,280.80 +56.9%1.5%1.7 $7.89 6/30/202315,300 shares $110,160.00 -94.1%0.9%1.3 $7.20 6/15/2023258,600 shares $116,628.60 +42.4%1.1%2.1 $0.45 5/31/2023181,600 shares $89,056.64 -27.0%0.8%1.6 $0.49 5/15/2023248,600 shares $111,870.00 -25.2%1.0%2.9 $0.45 4/30/2023332,400 shares $162,876.00 +21.4%1.4%3.9 $0.49 4/15/2023273,900 shares $127,116.99 -7.6%1.1%3 $0.46 3/31/2023296,300 shares $145,187.00 +6.0%1.2%3.4 $0.49 3/15/2023279,500 shares $156,799.50 +10.7%1.2%2.4 $0.56 2/28/2023252,400 shares $146,392.00 -10.6%1.1%2.2 $0.58 2/15/2023282,200 shares $172,508.86 +25.3%1.2%2.5 $0.61 1/31/2023225,300 shares $141,510.70 -4.1%0.9%2.1 $0.63 1/15/2023234,800 shares $135,362.20 -9.7%1.0%2.1 $0.58 12/30/2022260,000 shares $115,882.00 +10.5%1.1%2.1 $0.45 12/15/2022235,300 shares $128,709.10 +3.4%1.0%2.2 $0.55 11/30/2022227,600 shares $124,884.12 -1.0%1.0%2 $0.55 11/15/2022230,000 shares $115,046.00 -28.3%1.0%1.8 $0.50 10/31/2022320,900 shares $213,430.59 +13.0%1.3%1.5 $0.67 10/15/2022283,900 shares $196,118.12 +1.1%1.2%1.3 $0.69 9/30/2022280,800 shares $191,393.28 +14.3%1.2%1.4 $0.68 9/15/2022245,600 shares $219,222.56 -0.4%1.0%1.1 $0.89The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth TLIS Short Interest - Frequently Asked Questions What is Talis Biomedical's current short interest? Short interest is the volume of Talis Biomedical shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 13,400 shares of TLIS short. 0.80% of Talis Biomedical's shares are currently sold short. Learn More on Talis Biomedical's current short interest. What is a good short interest ratio for Talis Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLIS shares currently have a short interest ratio of 2.0. Learn More on Talis Biomedical's short interest ratio. What is a good short interest percentage for Talis Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.80% of Talis Biomedical's floating shares are currently sold short. Is Talis Biomedical's short interest increasing or decreasing? Talis Biomedical saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 13,400 shares, an increase of 8.9% from the previous total of 12,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Talis Biomedical's float size? Talis Biomedical currently has issued a total of 1,820,000 shares. Some of Talis Biomedical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Talis Biomedical currently has a public float of 1,670,000 shares. How does Talis Biomedical's short interest compare to its competitors? 0.80% of Talis Biomedical's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Talis Biomedical: Accelerate Diagnostics, Inc. (2.51%), Cue Health Inc. (0.46%), Precipio, Inc. (0.28%), Telesis Bio, Inc. (0.04%), Singular Genomics Systems, Inc. (1.57%), Rapid Micro Biosystems, Inc. (0.19%), Lucid Diagnostics Inc. (3.10%), Prenetics Global Limited (1.44%), BioSig Technologies, Inc. (5.54%), Psychemedics Co. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Talis Biomedical stock? Short selling TLIS is an investing strategy that aims to generate trading profit from Talis Biomedical as its price is falling. TLIS shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Talis Biomedical? A short squeeze for Talis Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLIS, which in turn drives the price of the stock up even further. How often is Talis Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLIS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AXDX Short Interest Data HLTH Short Interest Data PRPO Short Interest Data TBIO Short Interest Data OMIC Short Interest Data RPID Short Interest Data LUCD Short Interest Data PRE Short Interest Data BSGM Short Interest Data PMD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TLIS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends